Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lyra Therapeutics Inc
(NQ:
LYRA
)
5.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
5.210
Bid (Size)
4.880 (3)
Ask (Size)
5.550 (2)
Prev. Close
5.210
Today's Range
5.210 - 5.210
52wk Range
1.930 - 6.790
Shares Outstanding
31,836,815
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023
March 21, 2024
LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About Lyra Therapeutics
October 06, 2023
Via
Benzinga
Performance
YTD
+0.19%
+0.19%
1 Month
-15.42%
-15.42%
3 Month
+5.25%
+5.25%
6 Month
+55.06%
+55.06%
1 Year
+163.13%
+163.13%
More News
Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via
Benzinga
Lyra Therapeutics: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
Lyra Therapeutics's Return On Capital Employed Insights
March 30, 2023
Via
Benzinga
Lyra Therapeutics: Q2 Earnings Insights
August 09, 2022
Via
Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 26, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 08, 2022
Via
Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor
May 25, 2022
Via
Benzinga
Recap: Lyra Therapeutics Q1 Earnings
May 10, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
Via
Benzinga
Lyra's Mid-Stage Chronic Rhinosinusitis Candidate Study Progressed, Shares Fall
September 13, 2022
Via
Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 18, 2022
Via
Benzinga
Lyra Therapeutics's Return On Capital Employed Insights
June 10, 2022
Via
Benzinga
7 Stocks to Watch for Major Insider Trading Clues
April 27, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
May 24, 2022
Via
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 20, 2022
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.